Position in CELC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,096,980
-$1,051,283 QoQ
Shares Held
48,719
-9.6% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 274 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,919,080,283 across 424 Biotechnology names. CELC ranks #114 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in CELC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,096,980 | 48,719 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $6,148,263 | 53,866 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,092,623 | 51,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,571,022 | 52,045 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $183,041 | 13,711 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $157,906 | 15,619 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $192,200 | 14,683 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $179,022 | 12,007 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $386,877 | 23,619 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,276,862 | 59,114 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $248,359 | 17,046 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $108,217 | 11,840 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $146,703 | 13,361 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,065 | 982 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $69,629 | 4,970 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $42,402 | 4,535 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $48,907 | 3,708 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $133,074 | 7,393 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $224,928 | 9,372 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $57 | 4 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $36 | 4 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $40 | 7 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,729 | 394 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $63,687 | 9,798 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||